# A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation

> **NCT01484964** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 24 (actual)

## Conditions studied

- Pharmacokinetics of ASP015K
- Bioavailability of ASP015K
- Healthy Subjects

## Interventions

- **DRUG:** ASP015K

## Key facts

- **NCT ID:** NCT01484964
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484964, "A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01484964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*